Surgacoll

About Surgacoll

SurgaColl Technologies Ltd is a pioneer in the field of regenerative medicine. A spin out from the RCSI, the company is developing highly innovative tissue repair implants designed to enable cartilage and bone regeneration improving outcomes and standard of care for patients worldwide. SurgaColl has two products - HydroxyColl is a 'next generation' bone graft substitute and ChondroColl is a bio-mimetic three layer Cartilage repair implant.
LEADERSHIP:
CEO: William (Bill) Allan
FOLLOW SURGACOLL:

2 articles about Surgacoll